Luxembourg Government Awards €1 Million to Space Biotech Firm Exobiosphere
Luxembourg's Ministry of the Economy has awarded €1 million in non-dilutive funding to space biotech company Exobiosphere through its Jeune Entreprise Innovante (JEI) programme, supporting further development of the company's microgravity drug-discovery platform.
Luxembourg's Ministry of the Economy has awarded €1 million in non-dilutive funding to space biotech company Exobiosphere through its Jeune Entreprise Innovante (JEI) programme, supporting further development of the company's microgravity drug-discovery platform. Its flagship system, the Orbital High-Throughput Screener, runs experiments aboard space stations, leveraging microgravity conditions to support disease modeling and pharmaceutical research.
The goal is simple: make space a routine, essential part of the biomedical R&D pipeline, so we can bring better and faster treatments to patients, the company says.
Exobiosphere was launched in 2024 by Kyle Acierno, joined by co-founders Dr. Bruno Santos and Dr. Olivia Borgue. The startup has set out to build the world's first standardized, space-based high-throughput testing platform, giving pharmaceutical and biotech companies the means to run automated experiments in orbit at scale. "The goal is simple: make space a routine, essential part of the biomedical R&D pipeline, so we can bring better and faster treatments to patients," the company says.
This grant lands at exactly the right moment and makes a real difference for a company at our stage, said Kyle Acierno, co-founder and CEO of Exobiosphere.
The JEI aid targets research-intensive companies with strong growth potential, combining non-dilutive public funding with private investment to help them move into their next stage of growth. For Exobiosphere, the €1 million grant will help fund its commercial expansion, strengthen operations, and grow international business development and marketing, while supporting continued growth of its Orbital High-Throughput Screening platform.
“This grant lands at exactly the right moment and makes a real difference for a company at our stage. It allows us to expand our commercial activities, strengthen our team, and bring our technological offer to more pharmaceutical and biotech partners around the world. We’re grateful for the continued support of the Luxembourg innovation ecosystem and Ministry of Economy,” said Kyle Acierno, co-founder and CEO of Exobiosphere.
Source: Exobiosphere